Royce & Associates LP Soma Logic, Inc. Transaction History

Royce & Associates LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	BUY	$1.99 - $2.45 $65,317 - $80,416	32,823 Added 55.19%	92,293 $220,000
Q2 2023 Aug 07, 2023	BUY	$2.1 - $3.36 $13,377 - $21,403	6,370 Added 12.0%	59,470 $137,000
Q1 2023 May 04, 2023	BUY	$2.13 - $3.6 $47,925 - $81,000	22,500 Added 73.53%	53,100 $135,000
Q4 2022 May 23, 2023	SELL	$2.05 - $3.47 $46,124 - $78,075	-22,500 Reduced 42.37%	30,600 $76,000
Q4 2022 Feb 13, 2023	BUY	$2.05 - $3.47 $62,729 - $106,182	30,600 New	30,600 $77,000

7.48M

Ticker SLGC
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 183,452,992
Description
SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex prot...

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

Stay updated on Royce & Associates LP with notifications on news.